Bioventus Inc. (BVS) stock
BVSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 2, 2026Score 13/3042% below fair value
$10.46−0.20 (-1.88%)
Close on Nov 16, 2026Market cap $879.60MP/E 13.6Yield –
Bioventus market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Bioventus's market cap was $776.51M on Nov 11, 2026, against $510.18M a year earlier. Over the last 5 years it ranged from $62.00M to $951.98M, with a median of $443.70M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $776.51M | +55.3% |
| 2025 | Dec 31, 2025 | $500.10M | -25.5% |
| 2024 | Dec 31, 2024 | $671.48M | +104.3% |
| 2023 | Dec 29, 2023 | $328.62M | +109.8% |
| 2022 | Dec 30, 2022 | $156.65M | – |
See a number that looks wrong?